Literature DB >> 11527053

Awareness of osteoporosis and compliance with management guidelines in patients with newly diagnosed low-impact fractures.

H Castel1, D Y Bonneh, M Sherf, Y Liel.   

Abstract

A pre-existing fracture is a strong predictor of additional osteoporotic fractures. Consequently, current guidelines emphasize the need for treating patients with existing osteoporotic fractures. The present study aimed to assess the implementation of osteoporosis guidelines in routine practice. To this end, we reviewed the hospital charts of women and men aged 50 years and older with new fractures due to low or moderate impact treated in the emergency room, orthopedic surgery and rehabilitation departments. Notation of osteoporosis as a contributing cause for the fracture, performance of screening laboratory tests for possible secondary causes and treatment recommendations were abstracted from the record. In addition, we utilized the centralized pharmacy and laboratory computerized databases of the largest health maintenance organization in the area to follow dispensation of osteoporosis drugs and performance of screening laboratory tests in the community following fracture incidents. During the corresponding periods of January and February 1998 and 1999, 183 patients aged 50 years and older with low-impact fractures were treated in the emergency room only and 113 were hospitalized. Osteoporosis was rarely mentioned in the medical documentation. During the 6 month period after the fracture incident at least 70% of the emergency room patients and 62% of the hospitalized patients received no osteoporosis drugs. However, an encouraging significant trend toward increasing use of osteoporosis drugs, both prior to and after a fracture incident, was noted between the two survey periods among the emergency room fracture patients, but not among the hospitalized patients. Calcium supplements were the most commonly used osteoporosis drug. Bisphosphonates, hormone replacement therapy, raloxifene and calcitonin were rarely prescribed. Men were less likely than women to receive treatment for osteoporosis. Systematic laboratory evaluations for secondary causes of osteoporosis were not performed. We conclude that despite extensive attempts at increasing awareness among health professionals and the public at large, osteoporosis is still rarely singled out as a problem in patients with newly diagnosed low-impact fractures, and the majority of them are not managed according to guidelines. Further studies should address specific problems in physicians' and patients' attitude that may account for the present situation.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11527053     DOI: 10.1007/s001980170077

Source DB:  PubMed          Journal:  Osteoporos Int        ISSN: 0937-941X            Impact factor:   4.507


  36 in total

1.  Access to fracture risk assessment by FRAX and linked National Osteoporosis Guideline Group (NOGG) guidance in the UK-an analysis of anonymous website activity.

Authors:  E V McCloskey; H Johansson; N C Harvey; J Compston; J A Kanis
Journal:  Osteoporos Int       Date:  2016-07-20       Impact factor: 4.507

2.  Knowledge of orthopaedic surgeons in managing patients with fragility fracture.

Authors:  Reza Sorbi; Mohamad Reza Aghamirsalim
Journal:  Int Orthop       Date:  2012-01-27       Impact factor: 3.075

3.  An audit of bone densitometry practice with reference to ISCD, IOF and NOF guidelines.

Authors:  R Baddoura; H Awada; J Okais; M Salamoun; G Ayoub; N Ziadé; G El Hajj-Fuleihan
Journal:  Osteoporos Int       Date:  2006-05-03       Impact factor: 4.507

4.  Incidence and causes for failure of treatment of women with proven osteoporosis.

Authors:  Noah Zafran; Zvi Liss; Ronit Peled; Michael Sherf; Haim Reuveni
Journal:  Osteoporos Int       Date:  2005-04-02       Impact factor: 4.507

5.  Correlation between patient recall of bone densitometry results and subsequent treatment adherence.

Authors:  Cynthia S Pickney; Jon A Arnason
Journal:  Osteoporos Int       Date:  2005-03-03       Impact factor: 4.507

6.  The impact of a simple fracture clinic intervention in improving the diagnosis and treatment of osteoporosis in fragility fracture patients.

Authors:  Gillian Hawker; Rowena Ridout; Maria Ricupero; Susan Jaglal; Earl Bogoch
Journal:  Osteoporos Int       Date:  2003-03-04       Impact factor: 4.507

7.  Impact of subsidizing effective anti-osteoporosis drugs on compliance with management guidelines in patients following low-impact fractures.

Authors:  Yair Liel; Hana Castel; Dan Y Bonneh
Journal:  Osteoporos Int       Date:  2003-04-18       Impact factor: 4.507

Review 8.  Practice patterns in the diagnosis and treatment of osteoporosis after a fragility fracture: a systematic review.

Authors:  V Elliot-Gibson; E R Bogoch; S A Jamal; D E Beaton
Journal:  Osteoporos Int       Date:  2004-07-16       Impact factor: 4.507

9.  Secondary prevention of osteoporotic fractures--an "OPTIMAL" model of care from Singapore.

Authors:  M Chandran; M Z W Tan; M Cheen; S B Tan; M Leong; T C Lau
Journal:  Osteoporos Int       Date:  2013-04-25       Impact factor: 4.507

10.  Community-based randomised controlled trial evaluating falls and osteoporosis risk management strategies.

Authors:  P M Ciaschini; S E Straus; L R Dolovich; R A Goeree; K M Leung; C R Woods; G M Zimmerman; S R Majumdar; S Spadafora; L A Fera; H N Lee
Journal:  Trials       Date:  2008-11-04       Impact factor: 2.279

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.